KANGHUI PHARMACEUTICAL shareholder Salus Capital plans to reduce its holdings by no more than 3%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, KANGHUI PHARMACEUTICAL (603139.SH) announced that its shareholder Shanghai Sailoxian Enterprise Management Consulting Co., Ltd. (referred to as "Sailoxian") plans to reduce its holdings by a total of no more than 2.9964 million shares (i.e., no more than 3% of the total shares of the company) through centralized bidding and block trading within three months after fifteen trading days from the date of this announcement

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.